M. Plana

S. Yerly, M. Plana, J. Miro, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Dendritic Cells with Gold Nanoparticles (GNPs) Bearing HIV-Peptides and Mannosides Enhance HIV-Speciﬁc T Cell Responses

Felipe García, J. Gatell, M. Plana, 2017 .

Lymphoid tissue collagen deposition in HIV-infected patients correlates with the imbalance between matrix metalloproteinases and their inhibitors.

Antonio Martínez, Felipe García, M. Plana, 2011, The Journal of infectious diseases.

In vitro effects of the CCR5 inhibitor maraviroc on human T cell function.

M. Plana, J. Blanco, J. Gatell, 2013, The Journal of antimicrobial chemotherapy.

The protein kinase C-independent human B cell proliferation induced via surface immunoglobulins is unaffected by CD45 monoclonal antibodies.

M. Plana, J. Alberola-Ila, F. Lozano, 1991, Immunobiology.

Metabolic and Immunological Effects of Antiretroviral Agents in Healthy Individuals Receiving Post-Exposure Prophylaxis

Felipe García, G. Mestre, M. Plana, 2001, Antiviral therapy.

PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia

Felipe García, M. Plana, A. Meyerhans, 2015, PLoS pathogens.

Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial

M. Plana, A. Landay, Jacqueline Neuhaus, 2011, AIDS.

Autoantibodies against nuclear envelope‐associated proteins in primary biliary cirrhosis

M. Plana, T. Gallart, L. Borche, 1988, Hepatology.

Liver diseases associated with autoantibodies directed to nuclear envelope components

M. Plana, T. Gallart, D. Dhumeaux, 1989 .

A therapeutic dendritic cell-based vaccine for HIV-1 infection.

B. Clotet, J. Martinez-Picado, J. Romeu, 2011, The Journal of infectious diseases.

Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection.

M. Plana, V. Planelles, J. Alcamí, 2020, Biochemical pharmacology.

Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence

E. Campo, Felipe García, J. Gatell, 2005, Modern Pathology.

Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients

Antonio Martínez, Felipe García, M. Plana, 2010, AIDS.

The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity

B. Berkhout, Felipe García, M. Plana, 2017, Retrovirology.

Therapeutic vaccines against HIV infection

Felipe García, M. Plana, T. Gallart, 2012, Human vaccines & immunotherapeutics.

Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).

Felipe García, M. Plana, M. Arnedo, 2006, Enfermedades infecciosas y microbiologia clinica.

Posterior mushroom keratoplasty in patients with Fuchs endothelial dystrophy and pseudophakic bullous keratopathy: transplant outcome.

E. Campo, Antonio Martínez, Felipe García, 2008 .

Association of Transcriptomic Signatures of Inflammatory Response with Viral Control after Dendritic Cell-Based Therapeutic Vaccination in HIV-1 Infected Individuals

P. Aloy, M. Plana, M. Arnedo, 2021, Vaccines.

A Dendritic Cell–Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication

B. Clotet, J. Martinez-Picado, B. Autran, 2013, Science Translational Medicine.

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

Roger Paredes, Esteban Martinez, Bonaventura Clotet, 2018, The Journal of antimicrobial chemotherapy.

A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study

L. Lopalco, F. Lori, G. M. Ortiz, 2003, AIDS.

Local barrier dysfunction identified by confocal laser endomicroscopy predicts bacterial translocation in HIV infection.

M. Goetz, M. Plana, M. Pellisé, 2020, AIDS.

Long-Term CD4+ T-Cell Response to Highly Active Antiretroviral Therapy According to Baseline CD4+ T-Cell Count

Felipe García, G. Mestre, M. Plana, 2004, Journal of acquired immune deficiency syndromes.

Pharmacokinetics and Pharmacodynamics of Low Dose Mycophenolate Mofetil in HIV-Infected Patients Treated with Abacavir, Efavirenz and Nelfinavir

Felipe García, M. Plana, T. Pumarola, 2005, Clinical pharmacokinetics.

Effect of Mycophenolate Mofetil on Immune Response and Plasma and Lymphatic Tissue Viral Load During and After Interruption of Highly Active Antiretroviral Therapy for Patients With Chronic HIV Infection: A Randomized Pilot Study

Felipe García, M. Plana, M. Arnedo, 2004, Journal of Acquired Immune Deficiency Syndromes.

Genotypic and Phenotypic Resistance Patterns in Early-Stage HIV-1-Infected Patients Failing Initial Therapy with Stavudine, Didanosine and Nevirapine

Felipe García, G. Mestre, M. Plana, 2001, Antiviral therapy.

T-cell response to Toxoplasma gondii (Tg) antigens discriminates healthy individuals with and without c h ronic infection. Its interest to evaluate the reconstitution of Tg-specific CD4+ T cells in Tg- coinfected AIDS patients receiving antire t roviral therapy

M. Lejeune, Felipe García, M. Plana, 2001 .

Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease

Felipe García, M. Plana, T. Gallart, 1998, The Lancet.

Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review

M. Plana, J. Miro, J. Gatell, 2015, Expert review of anti-infective therapy.

Effects of highly active antiretroviral therapy on vaccine-induced humoral immunity in HIV-infected adults.

M. Plana, P. Castro, A. Vilella, 2010, HIV medicine.

Standard vaccines increase HIV-1 transcription during antiretroviral therapy

Felipe García, M. Plana, S. Gianella, 2016, AIDS.

Influence of a vaccination schedule on viral load rebound and immune responses in successfully treated HIV-infected patients.

Felipe García, M. Plana, T. Pumarola, 2009, AIDS research and human retroviruses.

Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B

C. Brander, Felipe García, M. Plana, 2019, Vaccines.

A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity

M. Plana, J. Miro, J. Gatell, 2018, AIDS.

Pharmacokinetics, the immunological impact and the effect on HIV ex-vivo infectivity of maraviroc, raltegravir and lopinavir in MSM using Post-exposure Prophylaxis.

J. Gatell, M. Plana, J. Llach, 2022, AIDS research and human retroviruses.

New challenges in therapeutic vaccines against HIV infection

Felipe García, M. Plana, T. Gallart, 2017, Expert review of vaccines.

Dendritic cell based vaccines for HIV infection

Felipe García, M. Plana, T. Gallart, 2013, Human vaccines & immunotherapeutics.

Felipe García Control of HIV-1 Replication Based Vaccine Elicits T Cell Responses Associated with − A Dendritic Cell

Felipe García, Brigitte Autran, Agathe León, 2012 .

MicroRNA Profile in CD 8 + T-Lymphocytes from HIV-Infected Individuals : Relationship with Antiviral Immune Response and Disease Progression

Felipe García, M. Plana, M. Arnedo, 2016 .

Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitis.

D. Podzamczer, M. Lejeune, Felipe García, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine

D. Torrents, Felipe García, M. Plana, 2021, Vaccines.

Analysis of protein kinase C theta inhibitors for the control of HIV-1 replication in human CD4+ T cells reveals an effect on retrotranscription in addition to viral transcription.

M. Plana, J. Alcamí, M. López-Huertas, 2015, Biochemical pharmacology.

Use of RT-Defective HIV Virions: New Tool to Evaluate Specific Response in Chronic Asymptomatic HIV-Infected Individuals

Felipe García, M. Plana, J. Gatell, 2013, PloS one.

Redistribution of FOXP3-Positive Regulatory T Cells From Lymphoid Tissues to Peripheral Blood in HIV-Infected Patients

E. Campo, Antonio Martínez, Felipe García, 2007, Journal of acquired immune deficiency syndromes.

Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/I.

M. Plana, Á. Soriano, C. Vidal, 2001, AIDS.

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection

Felipe García, M. Plana, Á. Soriano, 2000, AIDS.

Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states of HIV disease.

Felipe García, M. Plana, T. Gallart, 2000 .

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.

M. Plana, C. Vidal, A. Cruceta, 1999, AIDS.

Non‐myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopenia

Antonio Martínez, Felipe García, J. Gatell, 2011, European journal of haematology.

Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection.

M. Plana, E. Fernández, J. Miró, 2020, AIDS.

Prevalence, clinical characteristics and outcome of severe primary HIV-1 infection: a prospective cohort study.

M. Plana, J. Gatell, E. Fernández, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Neurological involvement in patients with acute/recent HIV-1 infection. A case-control study

M. Plana, J. Miró, D. Nicolás, 2017, Journal of NeuroVirology.

CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control

D. Heckerman, F. Pereyra, B. Walker, 2012, PloS one.

Effects on immune system and viral reservoir of a short-cycle antiretroviral therapy in virologically suppressed HIV-positive patients

M. Plana, E. Martinez, S. Sánchez-Palomino, 2019, AIDS.

Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients

Felipe García, M. Plana, T. Gallart, 2017, AIDS.

Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.

B. Clotet, L. Ruiz, J. Romeu, 1999, AIDS.

Immunological and virological findings in a patient with exceptional post-treatment control: a case report.

R. Paredes, M. Plana, J. Miro, 2022, The lancet. HIV.

The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses

M. Plana, M. Esteban, B. Perdiguero, 2023, Vaccines.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.

M. Plana, C. Vidal, A. Cruceta, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of TNF-α genetic variants and CCR5Δ32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards

Felipe García, M. Plana, A. León, 2010, BMC Medical Genetics.

HIV-Infected T Cells Presented by the Class I HLA of Direct Interrogation of Viral Peptides

À. Olvera, C. Brander, M. Plana, 2014 .

Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation

Felipe García, M. Plana, J. Gatell, 2014, Journal of the International AIDS Society.

Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection

J. Prado, Felipe García, M. Plana, 2017, Journal of Virology.

Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial

Felipe García, M. Plana, J. Gatell, 2021, Frontiers in Immunology.

Structured Treatment Interruptions and Low Doses of IL-2 in Patients with Primary HIV Infection. Inflammatory, Virological and Immunological Outcomes

M. Plana, T. Pumarola, T. Gallart, 2015, PloS one.

Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption.

Felipe García, M. Plana, T. Gallart, 2008, The Journal of antimicrobial chemotherapy.

Redistribution of FOXP 3-Positive Regulatory T Cells From Lymphoid Tissues to Peripheral Blood in HIV-Infected Patients

E. Campo, Antonio Martínez, Felipe García, 2022 .

Predictors of Tonsillar Tissue HIV-1 Viral Burden at Baseline and after 1 Year of Antiretroviral Therapy

Felipe García, G. Mestre, M. Plana, 2002, Antiviral therapy.

In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?

Felipe García, M. Plana, L. Leal, 2021, Viruses.

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

J. Martinez-Picado, C. Brander, Felipe García, 2018, AIDS.

Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)

C. Brander, Felipe García, M. Plana, 2016, AIDS.

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).

Felipe García, M. Plana, G. Pantaleo, 2011, Vaccine.

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization

Felipe García, M. Plana, J. Gatell, 2017, PloS one.

Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.

B. Clotet, J. Martinez-Picado, C. Brander, 2015, The Journal of antimicrobial chemotherapy.

The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens

Felipe García, M. Plana, J. Gatell, 2011, Journal of Virology.

Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same Antigen

Felipe García, M. Plana, C. Sorzano, 2021, Vaccines.

Persistent low C3 levels associated with meningococcal meningitis and membranoproliferative glomerulonephritis.

M. Plana, J. Fernandez-Solà, M. Ingelmo, 1990, American Journal of Nephrology.

Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial

M. Plana, T. Gallart, J. Miro, 2016, The Journal of antimicrobial chemotherapy.

A 24-week pilot study of dual maintenance therapy with raltegravir plus lamivudine.

M. Plana, J. Blanch, J. Mallolas, 2019, AIDS.

High rate of long-term clinical events after antiretroviral therapy resumption in HIV-positive patients exposed to antiretroviral therapy interruption

M. Plana, C. Fehér, L. Leal, 2021, AIDS.

Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³.

Felipe García, M. Plana, M. Arnedo, 2013, AIDS research and human retroviruses.

Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4+ T‐cell activation and dendritic cell maturation

N. Navaratnam, Felipe García, J. Gatell, 2016, Immunology and cell biology.

Short Communication: Natural killer cells and expression of KIR receptors in chronic HIV type 1-infected patients after different strategies of structured therapy interruption.

Felipe García, G. Mestre, M. Plana, 2008, AIDS research and human retroviruses.

Dynamics of T cells subsets and lymphoproliferative responses during structured treatment interruption cycles and after definitive interruption of HAART in early chronic HIV type-1-infected patients.

Felipe García, M. Plana, M. Arnedo, 2006, AIDS research and human retroviruses.

A classifier to predict viral control after antiretroviral treatment interruption in chronic HIV-1 infected patients.

P. Aloy, Felipe García, M. Plana, 2020, Journal of acquired immune deficiency syndromes.

Evaluation of resistance to HIV‐1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors

M. Plana, J. Alcamí, F. Cervantes, 2018, Biochemical pharmacology.

932P Impact of geriatric assessment on the management of older head and neck cancer patients

M. Plana, R. Mesía, M. Taberna, 2020 .

HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses

B. Clotet, B. Autran, Felipe García, 2015, Journal of Virology.

Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells.

M. Plana, M. Benkirane, J. Alcamí, 2016, Biochemical pharmacology.

Long-term clinical follow-up, without antiretroviral therapy, of patients with chronic HIV-1 infection with good virological response to structured treatment interruption.

Felipe García, M. Plana, A. Cruceta, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influence of episodes of intermittent viremia ("blips") on immune responses and viral load rebound in successfully treated HIV-infected patients.

Felipe García, M. Plana, T. Pumarola, 2013, AIDS research and human retroviruses.

Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patients.

Felipe García, M. Plana, T. Gallart, 2007, AIDS research and human retroviruses.

Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count.

M. Plana, M. Arnedo, J. Benito, 2019, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Relevance of HIV-1-Specific CD4+ Helper T-Cell Responses During Structured Treatment Interruptions in Patients With CD4+ T-Cell Nadir Above 400/mm3

G. M. Ortiz, D. Nixon, C. Fagard, 2004, Journal of acquired immune deficiency syndromes.

Immunologic Reconstitution After 1 Year of Highly Active Antiretroviral Therapy, With or Without Protease Inhibitors

M. Lejeune, Felipe García, M. Plana, 2002, Journal of acquired immune deficiency syndromes.

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

A. Borobia, B. Clotet, J. Prado, 2022, The Lancet Regional Health - Europe.

Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.

L. Lopalco, Felipe García, J. Gatell, 2007, The Journal of infectious diseases.

Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression

Felipe García, M. Plana, F. Borrego, 2017, Front. Immunol..

Effects of Different Antigenic Stimuli on Thymic Function and Interleukin-7/CD127 System in Patients with Chronic HIV Infection

Felipe García, M. Plana, T. Pumarola, 2014, Journal of acquired immune deficiency syndromes.

Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization

Felipe García, M. Plana, J. Gatell, 2018, PloS one.

Balance between activation and regulation of HIV-specific CD8+ T-cell response after modified vaccinia Ankara B therapeutic vaccination

C. Brander, Felipe García, M. Plana, 2016, AIDS.

The reconstitution of the thymus in immunosuppressed individuals restores CD4‐specific cellular and humoral immune responses

B. Clotet, L. Ruiz, J. Romeu, 2011, Immunology.

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients

P. Aloy, Felipe García, M. Plana, 2019, Open forum infectious diseases.

Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease

R. Paredes, D. Podzamczer, B. Clotet, 2015, AIDS.

Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).

Felipe García, M. Plana, M. Arnedo, 2006, Enfermedades Infecciosas y Microbiologia Clinica.

Structured interruptions of antiretroviral therapy in HIV infection. Lessons from a therapeutic strategy

M. Plana, T. Gallart, Felipe García, 2002 .

Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

J. Gelpí, M. Plana, Francisco Martínez-Jiménez, 2023, Vaccines.

Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4+ T‐cell activation and dendritic cell maturation

N. Navaratnam, Felipe García, J. Gatell, 2016, Immunology and cell biology.

E. Domingo, Felipe García, M. Plana, 2004, Journal of medical virology.

Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium

M. Plana, Francisco Martínez-Jiménez, C. Sorzano, 2024, NPJ vaccines.

Redistribution of FOXP3-Positive Regulatory T Cells From Lymphoid Tissues to Peripheral Blood in HIV-Infected Patients

E. Campo, Antonio Martínez, Felipe García, 2007, Journal of acquired immune deficiency syndromes.

Comparison of T‐Cell Subsets' Reconstitution After 12 Months of Highly Active Antiretroviral Therapy Initiated During Early Versus Advanced States of HIV Disease

J. Gatell, M. Plana, T. Gallart, 2000, Journal of acquired immune deficiency syndromes.

1058PDoes hyper-progression exist among head and neck cancer patients treated with immunotherapy?

M. Plana, I. Braña, A. Franco, 2017 .